These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8795368)

  • 41. Microbial inhibitory properties and stability of topotecan hydrochloride injection.
    Patel K; Craig SB; McBride MG; Palepu NR
    Am J Health Syst Pharm; 1998 Aug; 55(15):1584-7. PubMed ID: 9706184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth of bacteria in intravenous fluids under stimulated actual-use conditions.
    Hugbo PG; Imhanlahimi WA
    Am J Hosp Pharm; 1983 Jun; 40(6):998-1001. PubMed ID: 6408922
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survival of contaminating bacteria in over-the-counter artificial tears.
    Harris MG; Gee A; Kusumoto R; Lee H
    J Am Optom Assoc; 1996 Nov; 67(11):676-80. PubMed ID: 8979661
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microbial viability in preparations packaged for single use.
    Obayashi A; Oie S; Kamiya A
    Biol Pharm Bull; 2003 May; 26(5):667-70. PubMed ID: 12736509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Soluble squalamine tablets for the rapid disinfection of home nebulizers of cystic fibrosis patients.
    Djouhri-Bouktab L; Alhanout K; Andrieu V; Stremler N; Dubus JC; Raoult D; Rolain JM; Brunel JM
    J Cyst Fibros; 2012 Dec; 11(6):555-9. PubMed ID: 22727722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pros and cons of preservatives in eyedrops. Questionnaire for practitioners and experimental studies with reference to the requirements of the German Pharmacopoeia of August 1978].
    Conrads H; Winterhoff D; Strotmann U
    Klin Monbl Augenheilkd; 1984 Mar; 184(3):233-7. PubMed ID: 6727243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival and detection of Bacillus cereus in the presence of Escherichia coli, Salmonella enteritidis, Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans after rechallenge in make-up removers.
    Yossa N; Arce G; Smiley J; Jo Huang MC; Yin L; Bell R; Tallent S; Brown E; Hammack T
    Int J Cosmet Sci; 2018 Feb; 40(1):67-74. PubMed ID: 29030872
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microbial growth patterns in intravenous fat emulsions.
    Keammerer D; Mayhall CG; Hall GO; Pesko LJ; Thomas RB
    Am J Hosp Pharm; 1983 Oct; 40(10):1650-3. PubMed ID: 6416063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Self-application of single-use eyedrop containers in an elderly population: comparisons with standard eyedrop bottle and with younger patients.
    Dietlein TS; Jordan JF; Lüke C; Schild A; Dinslage S; Krieglstein GK
    Acta Ophthalmol; 2008 Dec; 86(8):856-9. PubMed ID: 18494743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pseudomonas aeruginosa growth in Refresh Plus®.
    Pinna A; Usai D; Zanetti S
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):561-4. PubMed ID: 21838521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of protective effects of sodium hyaluronate eyedrop against corneal epithelial disorders using an electrophysiological method.
    Araki R; Nakashima M; Teshima M; Owaki Y; Nakashima MN; Uematsu M; Kitaoka T; Nakamura T; Kitahara T; Sasaki H
    J Ocul Pharmacol Ther; 2012 Jun; 28(3):251-8. PubMed ID: 22324441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SAP-containing dressings exhibit sustained antimicrobial effects over 7 days in vitro.
    Wiegand C; Abel M; Muldoon J; Ruth P; Hipler UC
    J Wound Care; 2013 Mar; 22(3):120, 122-4, 126-7. PubMed ID: 23665730
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibacterial and antifungal properties of human cerumen.
    Lum CL; Jeyanthi S; Prepageran N; Vadivelu J; Raman R
    J Laryngol Otol; 2009 Apr; 123(4):375-8. PubMed ID: 18694532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [In vitro effects of antiallergic eyedrops on complement activation induced by particulate matter].
    Blondin C; Cholley B; Haeffner-Cavaillon N; Goldschmidt P
    J Fr Ophtalmol; 2003 Apr; 26(4):328-36. PubMed ID: 12843888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Antimicrobial agents in eyedrops].
    Sklubalová Z
    Ceska Slov Farm; 2004 May; 53(3):107-16. PubMed ID: 15218731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Low-level challenge test for the examination of the microbiological susceptibility, during the period of use, of liquid and semi-solid dosage forms in multiple-dose containers (author's transl)].
    Urban S; Hecker W; Schiller I
    Zentralbl Bakteriol Mikrobiol Hyg B; 1981; 172(6):478-84. PubMed ID: 7257652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the sterility and stability of insulin from multidose vials used for prolonged periods.
    Rathod M; Saravolatz L; Pohlod D; Whitehouse F; Goldman J
    Infect Control; 1985 Dec; 6(12):491-4. PubMed ID: 3935593
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single Administration of a Biodegradable, Separable Microneedle Can Substitute for Repeated Application of Eyedrops in the Treatment of Infectious Keratitis.
    Park S; Lee K; Kang H; Lee Y; Lee J; Kim JH; Song HB; Ryu W
    Adv Healthc Mater; 2021 Jun; 10(11):e2002287. PubMed ID: 33930253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye.
    Matsuo T
    Jpn J Ophthalmol; 2004; 48(4):321-7. PubMed ID: 15295655
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low-level efficacy of cosmetic preservatives.
    Lundov MD; Johansen JD; Zachariae C; Moesby L
    Int J Cosmet Sci; 2011 Apr; 33(2):190-6. PubMed ID: 21272037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.